Richard Dean Dr McCormick
Stock Price at Trade vs. Today
Real market data showing how each stock moved since the congress member traded it.
Suspicious Timing Detected
5 flagsRichard Dean Dr McCormick bought $1,001 - $15,000 in $AMT on 2023-03-15, 855 days before HR4477 ("PRICE Act") was introduced, which could create new funding for infrastructure improvements.
Richard Dean Dr McCormick bought $1,001 - $15,000 in $ADP on 2023-03-15, 859 days before HR4548 ("Small Nonprofit Retirement Security Act of 2025") was introduced, expanding tax credits for retirement plans.
Richard Dean Dr McCormick bought $1,001 - $15,000 in $COST on 2023-03-15, 867 days before S2512 ("EATS Act of 2025") was introduced, potentially boosting demand for grocery products.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $ABT | Abbott Laboratories Common Stock (ABT) | $1K-$15K | — | $92.48 | — | Mar 15, 2023 |
| BUY | $APD | Air Products and Chemicals, Inc. Common Stock (APD) | $1K-$15K | — | — | — | Mar 15, 2023 |
| BUY | $AMT | American Tower Corporation (AMT) | $1K-$15K | — | — | — | Mar 15, 2023 |
| BUY | $AWK | American Water Works Company, Inc. Common Stock (AWK) | $1K-$15K | — | — | — | Mar 15, 2023 |
| BUY | $ADI | Analog Devices, Inc. - Common Stock (ADI) | $1K-$15K | — | — | — | Mar 15, 2023 |
| BUY | $AAPL | Apple Inc. - Common Stock (AAPL) | $1K-$15K | $152.99 | $273.43 | +78.7% | Mar 15, 2023 |
| BUY | $ADP | Automatic Data Processing, Inc. - Common Stock (ADP) | $1K-$15K | — | $198.53 | — | Mar 15, 2023 |
| BUY | Mutual Fund | Baron Asset Fund Inst Shs (BARIX)(Mutual Fund) | $1K-$15K | — | — | — | Mar 15, 2023 |
| BUY | Mutual Fund | Baron Emerging Markets Fd Inst Shs (BEXIX)(Mutual Fund) | $1K-$15K | — | — | — | Mar 15, 2023 |
| BUY | $BLK | BlackRock, Inc. Common Stock (BLK) | $1K-$15K | — | — | — | Mar 15, 2023 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
PrEP and PEP are Prevention Act
The PrEP and PEP are Prevention Act mandates no-cost coverage for HIV prevention drugs and related services, directly increasing demand for these medications and associated diagnostic tests. This legislation creates a guaranteed market expansion for pharmaceutical companies producing PrEP/PEP drugs and diagnostic providers, while increasing costs for health insurers.
Food Date Labeling Act of 2025
The Food Date Labeling Act of 2025 (S. 2541) is in its early legislative stages, having been introduced and referred to committee. This bill aims to standardize food date labels, which could lead to minor compliance costs for food retailers and distributors, but also potential benefits from reduced spoilage and improved inventory management. Market data shows mixed recent performance for major food retailers and distributors.
PRICE Act
The PRICE Act establishes a grant program for manufactured housing community improvements, creating a new funding stream for infrastructure upgrades and resident-controlled entities. This directly increases asset values and operational efficiency for owners and operators of affordable manufactured housing communities. The bipartisan sponsorship indicates a high probability of passage.
End the Vaccine Carveout Act
The 'End the Vaccine Carveout Act' removes liability protections for vaccine manufacturers, directly increasing their legal and operational risks. This bill, if enacted, will significantly alter the risk profile and profitability of pharmaceutical companies producing vaccines. Companies like Pfizer, Moderna, GSK, and Johnson & Johnson face increased litigation exposure.
MAPWaters Act of 2025
The MAPWaters Act of 2025 mandates federal agencies to standardize and publish geospatial data for public waterways. This creates a new market for data management and mapping services, benefiting companies specializing in GIS and mapping technologies.
Price Gouging Prevention Act of 2025
The Price Gouging Prevention Act of 2025 directly limits corporate profitability for large-cap companies during 'exceptional market shock' events by mandating pre-shock margin maintenance. This legislation increases regulatory risk and caps potential upside for companies with significant market power across all sectors, leading to decreased profitability during crises. All major corporations face reduced profit potential and increased compliance costs.
Small Nonprofit Retirement Security Act of 2025
The Small Nonprofit Retirement Security Act of 2025 expands tax credits for retirement plan startup costs and auto-enrollment to tax-exempt small employers, directly increasing the total addressable market for financial services and payroll processing companies. This creates a new revenue stream for providers of retirement plan administration, payment processing, and financial data services.
Blue Shield Privacy Act of 2025
The Blue Shield Privacy Act of 2025, HR4828, expands privacy protections to include biometric data, license plate numbers, workplace/school addresses, and GPS coordinates. This bill, currently in its early stages, creates new compliance burdens for companies collecting and processing such data. The broad scope indicates potential increased operational costs for major data-driven companies.
EATS Act of 2025
The EATS Act of 2025 expands SNAP eligibility to all otherwise eligible college students, immediately boosting demand for grocery and food products. This legislation creates a significant new revenue stream for major retailers and food distributors, directly increasing sales volumes.
Stop Chinese Fentanyl Act of 2025
The 'Stop Chinese Fentanyl Act of 2025' (HR747) is an early-stage bill that expands sanctions on Chinese entities involved in opioid and precursor production. This legislation directly impacts U.S. companies with chemical supply chain ties to China, increasing operational costs and creating potential supply chain disruptions for chemical manufacturers and logistics firms. The bill has seen recent committee activity, indicating some legislative momentum.
Live Charts
Other Filings by Richard Dean Dr McCormick
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.